Literature DB >> 1906489

Primary and secondary detoxification in severe flecainide intoxication.

D Götz1, S Pohle, D Barckow.   

Abstract

Since experience with primary and secondary detoxification in severe flecainide intoxications is limited, 2 different cases of flecainide intoxications are reported. In the first case, with plasma concentrations of 6500 ng/ml (therapeutic range: 200-980 ng/ml), the patient survived with a pacemaker and catecholamine support. In the second case, hemoperfusion terminated the need for emergency resuscitation during the initial phase, but was unsuccessful 3 h later. Even with a lower plasma concentration the patient died. Both patients had rapid onset of symptoms due to the very good bioavailability of the drug. Although it may be a rare intoxication, it is dangerous because of its quick onset and its efficiency in altering the cardiac stability. We recommend the prophylactic use of a pacemaker and gastric suction. The usefulness of hemoperfusion has not yet been proven.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906489     DOI: 10.1007/bf01704725

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

1.  Clinical course and outcome in class IC antiarrhythmic overdose.

Authors:  C Köppel; U Oberdisse; G Heinemeyer
Journal:  J Toxicol Clin Toxicol       Date:  1990

2.  [Hemoperfusion in flecainide poisoning].

Authors:  R Wurzberger; E Witter; H Avenhaus; H Hennemann; J U Becker
Journal:  Klin Wochenschr       Date:  1986-05-02

3.  Failure of haemoperfusion to reduce flecainide intoxication. A case study.

Authors:  J Braun; J R Kollert; U Gessler; J U Becker
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

4.  The influence of urinary pH on flecainide excretion and its serum pharmacokinetics.

Authors:  K A Muhiddin; A Johnston; P Turner
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

5.  [Inhibition of flecainide resorption by activated charcoal].

Authors:  J Nitsch; U Köhler; B Lüderitz
Journal:  Z Kardiol       Date:  1987-05

6.  Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function.

Authors:  J Braun; J R Kollert; J U Becker
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Hemofiltration clearance of flecainide in a patient with acute renal failure.

Authors:  A Borgeat; J Biollaz; B Freymond; M Bayer-Berger; R Chiolero
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

8.  Oral flecainide acetate for the treatment of ventricular arrhythmias.

Authors:  J L Anderson; J R Stewart; B A Perry; D D Van Hamersveld; T A Johnson; G J Conard; S F Chang; D C Kvam; B Pitt
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

9.  Flecainide pharmacokinetics in healthy volunteers: the influence of urinary pH.

Authors:  A Johnston; S Warrington; P Turner
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

  9 in total
  3 in total

1.  [Fatal flecainide intoxication in a 17-year-old girl].

Authors:  M Dokter; G Talarico; S Armbrust; E Below; B Bockholdt
Journal:  Anaesthesist       Date:  2018-03-28       Impact factor: 1.041

2.  Fatal flecainide intoxication.

Authors:  E Brazil; G G Bodiwala; D C Bouch
Journal:  J Accid Emerg Med       Date:  1998-11

3.  Successful treatment of flecainide overdose with sustained mechanical circulatory support.

Authors:  Anant Mandawat; Stephen A McCullough; Lauren G Gilstrap; Robert W Yeh
Journal:  HeartRhythm Case Rep       Date:  2015-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.